Ovipast Plus suspension for injection for sheep
Ovipast Plus suspension for injection for sheep
Authorised
- Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
- Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
- Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
- Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
- Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
- Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
- Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
Product identification
Medicine name:
Ovipast Plus suspension for injection for sheep
Active substance:
- Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
- Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
- Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
- Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
- Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
- Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
- Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
Target species:
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated500000000.00/cells1.00millilitre(s)
-
Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated500000000.00/cells1.00millilitre(s)
-
Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated500000000.00/cells1.00millilitre(s)
-
Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated500000000.00/cells1.00millilitre(s)
-
Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated500000000.00/cells1.00millilitre(s)
-
Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated500000000.00/cells1.00millilitre(s)
-
Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated500000000.00/cells1.00millilitre(s)
-
Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated500000000.00/cells1.00millilitre(s)
-
Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated500000000.00/cells1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Sheep
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- box containing 1 vial of 500 ml
- box containing 1 vial of 100 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
- MSD Animal Health UK Limited
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 62891/05/25-01-2008/K-0140301
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0326/001
Concerned member states:
-
Greece
-
Ireland
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
Summary of Product Characteristics
English (PDF)
Download Published on: 22/10/2025
Greek (PDF)
Published on: 2/10/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 2/10/2025